Drug product
Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02.
D-1517-2019
Product summary
- Firm
- Tris Pharma Inc.
- Event
- Event 83346
- Status
- Terminated
- Classification
- Class II
- Quantity
- 2,550 bottles
- Official record key
drug-enforcement:D-1517-2019
Official wording
Reason: Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.
Code information: Lot#: 14079, Exp 10/2021
Distribution pattern: Nationwide in the USA and Puerto Rico
Derived failure modes
-
Potency or specification failure
Superpotent